Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Sclerosis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRoyal Brompton & Harefield NHS Foundation Trust

About this trial

The specific aim of this study is to try to discover the diagnostic accuracy of SleepImage technology for detecting respiratory failure in patients with MND. Importantly, this research project is not about NIV, it is about what method can most efficiently decide when to start NIV.

To do this we'd like to collect data about you and your breathing from the SleepImage device when you come in for your routine overnight sleep study. We will compare this against the data that we would collect anyway.

Eligibility criteria

Qualifiers

Patients aged 18 and over with a Neurologist confirmed diagnosis of ALS

Disqualifiers

Patients with known respiratory disease

Unstable cardiac disease, stable hypertension or ischaemic heart disease

Current NIV use

Inability to give consent (expected ~15% due to frontotemporal dementia)

Trial design

Treatments tested in this trial

  • SleepImage

Treatment groups

15 Participants
are divided into 1 treatment group